| __timestamp | Dr. Reddy's Laboratories Limited | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 75801000000 | 19764000 |
| Thursday, January 1, 2015 | 85403000000 | 67426000 |
| Friday, January 1, 2016 | 92281000000 | 59752000 |
| Sunday, January 1, 2017 | 78356000000 | 65383000 |
| Monday, January 1, 2018 | 76304000000 | 70165000 |
| Tuesday, January 1, 2019 | 83430000000 | 44738000 |
| Wednesday, January 1, 2020 | 94009000000 | 39457000 |
| Friday, January 1, 2021 | 103077000000 | 97894000 |
| Saturday, January 1, 2022 | 113840000000 | 115306000 |
| Sunday, January 1, 2023 | 202972000000 | 453552000 |
| Monday, January 1, 2024 | 163607000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, Dr. Reddy's Laboratories Limited and HUTCHMED (China) Limited have emerged as key players. From 2014 to 2023, Dr. Reddy's Laboratories showcased a remarkable growth trajectory, with gross profits soaring by over 167%, peaking in 2023. This growth underscores their strategic market positioning and robust product pipeline.
Conversely, HUTCHMED's journey reflects a more modest ascent, with gross profits increasing by approximately 2,200% over the same period, albeit from a much smaller base. Their growth, while impressive in percentage terms, highlights the challenges of scaling in a competitive market.
The data reveals a stark contrast in scale and growth dynamics between these two companies, offering insights into their strategic priorities and market challenges. As we look to the future, the absence of data for 2024 for HUTCHMED suggests potential volatility or strategic shifts.
Gross Profit Trends Compared: Merck & Co., Inc. vs Dr. Reddy's Laboratories Limited
Key Insights on Gross Profit: Novartis AG vs Dr. Reddy's Laboratories Limited
Key Insights on Gross Profit: GSK plc vs Dr. Reddy's Laboratories Limited
Key Insights on Gross Profit: Biogen Inc. vs Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited and Ascendis Pharma A/S: A Detailed Gross Profit Analysis
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Bausch Health Companies Inc.
Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Gross Profit Comparison: Vericel Corporation and HUTCHMED (China) Limited Trends
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated